Addressing Genomic Disparities in Cancer Survivors

解决癌症幸存者的基因组差异

基本信息

  • 批准号:
    10813426
  • 负责人:
  • 金额:
    $ 67.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-03-09 至 2028-01-31
  • 项目状态:
    未结题

项目摘要

Genetic testing (GT) for hereditary cancer and related health services do not reach all segments of the population equitably. Racial disparities in genomic care are profound, persistent, and growing. Less than 30% of high-risk cancer patients are referred for germline GT, with appreciably lower referral and testing rates among racial minorities, especially among Blacks. GT of cancer survivors can directly inform treatment following progression or treatment resistance and can facilitate primary and secondary prevention of cancers in their unaffected relatives. Demand for GC (genetic counseling) and GT continues to increase with expanding GT indications and decreasing sequencing costs yet supply of genetic counselors remains limited. The conventional approach of referral to pretest genetic counseling is a common barrier to receiving GT. Further, evidence suggests that traditional comprehensive, pre-test GC does not meet the needs of many survivors, especially underserved minorities. Thus, new models of genome-based care are needed that are responsive to community needs, improve access, do not overburden scarce genetic counseling resources, and do not widen existing disparities. Some health care systems and commercial GT laboratories use digital interventions, including videos and relational agents (RAs), instead of traditional pre-test GC sessions, without providing specifics about community engagement development, acceptability, or efficacy in oncology settings through a rigorous methodologic strategy as we propose. Given the life-saving benefits of GT, understanding how to effectively educate, empower and test high-risk patients in a culturally acceptable way can move the field forward and reduce persistent racial disparities. This study will address this translational gap. In response to community identified needs and enthusiastic support from cancer patients, relatives and community advocates while also building on our pilot work, we will enroll 428 Black cancer patients meeting national guidelines for GT into a 2-arm randomized controlled trial. This approach may be of particular benefit to hundreds of thousands Black patients and their relatives because they are often unaware of their risks, less likely to have a provider discuss their risk and refer them for GT at the time of diagnosis and are not equably garnering the potentially lifesaving benefits of personalized prevention, screening, and treatment. The specific aims are to: 1) Compare the efficacy of a culturally tailored RA vs. Enhanced Usual Care (EUC) on engagement in genetic education and GT uptake; 2) Evaluate the impact of the RA vs. EUC on informed decision-making and psychosocial outcomes; and 3) Explore potential mechanisms by assessing mediators and moderations of effectiveness. Data from this trial can be used to guide clinical practice and policy decisions for advancing cancer health equity and improving access to genetic education and GT. If successful, this approach could be applied to other cancers and chronic conditions.
遗传性癌症的基因检测和相关的保健服务并没有覆盖所有阶层, 人口公平。基因组护理中的种族差异是深刻的,持久的,并不断增长。低于30% 的高风险癌症患者被转介进行生殖细胞GT,转介率和检测率明显降低 少数民族,尤其是黑人。癌症幸存者的GT可以直接告知治疗 在癌症进展或治疗耐药性之后, 未受影响的亲戚对GC(遗传咨询)和GT的需求继续增加, GT适应症和降低测序成本,但遗传咨询师的供应仍然有限。的 转介到预测试遗传咨询的常规方法是接受GT的常见障碍。此外, 有证据表明,传统的全面的、预先测试的GC不能满足许多幸存者的需要, 尤其是弱势群体。因此, 需要基于基因组的护理, 社区需求,改善可及性,不使稀缺的遗传咨询资源负担过重, 存在的差距。一些医疗保健系统和商业GT实验室使用数字干预, 包括视频和关系代理(RA),而不是传统的预测试GC会话, 关于社区参与发展、可接受性或肿瘤学环境中的疗效的具体信息, 严格的方法论策略。鉴于GT的救生优势,了解如何 以文化上可接受的方式对高危患者进行有效的教育、赋权和检测, 消除和消除长期存在的种族不平等。这项研究将解决这个翻译差距。响应于 社区认同癌症患者、亲属和社区倡导者的需求和热情支持 在我们的试点工作的基础上,我们将招募428名符合国家指导方针的黑人癌症患者, GT纳入一项2组随机对照试验。这种方法可能对数百人特别有益。 成千上万的黑人患者及其亲属,因为他们往往不知道他们的风险,不太可能有一个 提供者讨论他们的风险,并在诊断时将他们转介给GT, 个性化预防、筛查和治疗可能具有挽救生命的益处。具体目标是:1) 比较文化定制的RA与增强的生殖保健(EUC)在参与遗传学研究方面的疗效。 2)评估RA与EUC对知情决策的影响, 心理社会结果;和3)通过评估中介和调节, 有效性该试验的数据可用于指导临床实践和政策决策, 癌症健康公平以及改善遗传教育和遗传学治疗的机会。如果成功,这种方法可能会 适用于其他癌症和慢性疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anita Y. Kinney其他文献

Project HERO: a randomized trial of Tai Chi qigong versus intensity-matched exercise and usual care for fatigue in older male cancer survivors
  • DOI:
    10.1186/s12906-025-04988-7
  • 发表时间:
    2025-07-04
  • 期刊:
  • 影响因子:
    3.400
  • 作者:
    Anita Y. Kinney;Jinghua An;Yong Lin;Samuel Tundealao;Biren Saraiya;Shou-En Lu;Dolores D. Guest;Elizabeth M. Harding;Fabiano Amorim;Emily Heidt;Evelyn Arana-Chicas;Chunxia Chen;Tawny Boyce;Isaac Y. Kim;Wadih Arap;Cindy K. Blair;Michael R. Irwin
  • 通讯作者:
    Michael R. Irwin
Breast cancer beliefs and screening behaviors among South Asian immigrant women living in the United States
  • DOI:
    10.1186/s12905-025-03634-1
  • 发表时间:
    2025-03-04
  • 期刊:
  • 影响因子:
    2.700
  • 作者:
    Racquel E. Kohler;Tina Dharamdasani;Jacelyn Tarn;Myneka Macenat;Jeanne M. Ferrante;Shailja Mathur;Elisa V. Bandera;Anita Y. Kinney;Jaya M. Satagopan
  • 通讯作者:
    Jaya M. Satagopan
Religiosity, Spirituality, and Cancer Fatalism Beliefs on Delay in Breast Cancer Diagnosis in African
非洲乳腺癌诊断延迟的宗教、灵性和癌症宿命论信仰
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. Gullatte;O. Brawley;Anita Y. Kinney;Barbara D. Powe;Kathi Mooney
  • 通讯作者:
    Kathi Mooney

Anita Y. Kinney的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anita Y. Kinney', 18)}}的其他基金

Multilevel factors associated with disparities in the use of targeted cancer therapies in Medicare
与医疗保险中靶向癌症治疗使用差异相关的多层次因素
  • 批准号:
    10830588
  • 财政年份:
    2023
  • 资助金额:
    $ 67.95万
  • 项目类别:
Comparative Effectiveness of Interventions to Increase Guideline-based Genetic Counseling in Ethnically and Geographically Diverse Cancer Survivors
针对不同种族和地域的癌症幸存者增加基于指南的遗传咨询的干预措施的比较有效性
  • 批准号:
    10053322
  • 财政年份:
    2016
  • 资助金额:
    $ 67.95万
  • 项目类别:
Comparative Effectiveness of Interventions to Increase Guideline-based Genetic Counseling in Ethnically and Geographically Diverse Cancer Survivors
针对不同种族和地域的癌症幸存者增加基于指南的遗传咨询的干预措施的比较有效性
  • 批准号:
    9215545
  • 财政年份:
    2016
  • 资助金额:
    $ 67.95万
  • 项目类别:
Bridging Geographic Barriers: Remote Cancer Genetics Counseling for Rural Women
跨越地理障碍:为农村妇女提供远程癌症遗传学咨询
  • 批准号:
    8756063
  • 财政年份:
    2013
  • 资助金额:
    $ 67.95万
  • 项目类别:
Impact of Remote Familial Risk Assessment and Counseling
远程家庭风险评估和咨询的影响
  • 批准号:
    8756106
  • 财政年份:
    2013
  • 资助金额:
    $ 67.95万
  • 项目类别:
Cancer Control and Population Science Program
癌症控制和人口科学计划
  • 批准号:
    8180716
  • 财政年份:
    2010
  • 资助金额:
    $ 67.95万
  • 项目类别:
Bridging Geographic Barriers: Remote Cancer Genetics Counseling for Rural Women
跨越地理障碍:为农村妇女提供远程癌症遗传学咨询
  • 批准号:
    8128613
  • 财政年份:
    2009
  • 资助金额:
    $ 67.95万
  • 项目类别:
Bridging Geographic Barriers: Remote Cancer Genetics Counseling for Rural Women
跨越地理障碍:为农村妇女提供远程癌症遗传学咨询
  • 批准号:
    8469399
  • 财政年份:
    2009
  • 资助金额:
    $ 67.95万
  • 项目类别:
Bridging Geographic Barriers: Remote Cancer Genetics Counseling for Rural Women
跨越地理障碍:为农村妇女提供远程癌症遗传学咨询
  • 批准号:
    8270572
  • 财政年份:
    2009
  • 资助金额:
    $ 67.95万
  • 项目类别:
Biobehavioral Effects of Tai Chi Chih Among Elderly Breast Cancer Survivors
太极拳对老年乳腺癌幸存者生物行为的影响
  • 批准号:
    7662806
  • 财政年份:
    2009
  • 资助金额:
    $ 67.95万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 67.95万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 67.95万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 67.95万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 67.95万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 67.95万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 67.95万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 67.95万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 67.95万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 67.95万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 67.95万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了